TUESDAY, Feb. 20, 2024 (HealthDay News) — Women who carry certain mutations in their BRCA1 or BRCA2 genes know they are at heightened odds for breast cancer. Now, Canadian research suggests that for some patients a “risk-reducing” preventive mastectomy may cut the odds of dying from breast cancer later. “TheContinue Reading

MONDAY, Feb. 19, 2024 (HealthDay News) — The U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer. Amtagvi, made by Iovance Biotherapeutics Inc., becomes the first cellular therapy approved to treat this form of solid tumor cancer. “Unresectable, orContinue Reading

THURSDAY, Feb. 15, 2024 (HealthDay News) — The harms of smoking are many, but new research delivers evidence of another troubling type of damage: Lighting up alters your immune system, leaving you more vulnerable to disease and infections even years after quitting. “Stop smoking as soon as possible,” study co-authorContinue Reading

Immunotherapy can improve outcomes in patients undergoing surgery for soft-tissue sarcoma Immunotherapy and radiation therapy prior to surgery led to 90% of patients having nearly all cancer cleared from their bodies Overall five-year survival rates were 90% and 82% for two common forms of soft-tissue sarcoma THURSDAY, Feb. 15, 2024Continue Reading

WEDNESDAY, Feb. 14, 2024 (HealthDay News) — Everyone’s heard of fighting fire with fire. Now that tactic is coming to breast cancer treatment. Researchers think they’ve figured out a better way to fight breast cancer fueled by the female hormone estrogen – by employing mechanisms used by the male hormoneContinue Reading